Information  X 
Enter a valid email address

MaxCyteInc $0.01DI (MXCT)

Date Time Source Announcement
17 Jun 2022 2:51 pm
RNS
Holdings in Company
06 Jun 2022 7:00 am
RNS
Publication of Annual Report
27 May 2022 7:00 am
RNS
Notice of AGM
16 May 2022 7:00 am
RNS
Inducement Grants
10 May 2022 7:00 am
RNS
Filing of Form 10-Q
  7:00 am
RNS
MaxCyte Reports First Quarter Financial Results
04 May 2022 7:00 am
RNS
Upcoming Investor Conferences
29 Apr 2022 2:41 pm
RNS
Total Voting Rights
19 Apr 2022 7:00 am
RNS
Inducement Grants Under Nasdaq Listing Rule 5635
13 Apr 2022 7:00 am
RNS
Departure of CFO and Preliminary Q1 2022 Revenue
11 Apr 2022 7:00 am
RNS
Holding(s) in Company
01 Apr 2022 7:02 am
RNS
Total Voting Rights
28 Mar 2022 1:19 pm
RNS
Grant of Options and PDMR Dealing
23 Mar 2022 7:00 am
RNS
Fourth Quarter and Full Year Financial Results
10 Mar 2022 7:00 am
RNS
MaxCyte, Names Cenk Sumen Chief Scientific Officer
08 Mar 2022 2:29 pm
RNS
Holding(s) in Company
03 Mar 2022 9:45 am
RNS
Holding(s) in Company
01 Mar 2022 7:00 am
RNS
Block Listing Return
24 Feb 2022 1:00 pm
RNS
Notice of Results
22 Feb 2022 3:56 pm
RNS
Holding(s) in Company
21 Feb 2022 7:00 am
RNS
Consolidation of Trading Lines
14 Feb 2022 1:00 pm
RNS
Upcoming Investor Conferences
  7:00 am
RNS
Inducement Grants Under Nasdaq Listing Rule
01 Feb 2022 7:00 am
RNS
License with Intima Bioscience
24 Jan 2022 7:30 am
RNS
Preliminary Unaudited Q4 & FY 2021 Revenue Results
29 Dec 2021 3:30 pm
RNS
Holdings in Company
01 Dec 2021 5:00 pm
RNS
Total Voting Rights
23 Nov 2021 7:32 am
RNS
Purchase of Common Stock
17 Nov 2021 5:36 pm
RNS
Exercise of options and PDMR Dealing
11 Nov 2021 7:00 am
RNS
MaxCyte Reports Third Quarter Financial Results
03 Nov 2021 1:00 pm
RNS
Appointment of Chairman of the Board

a d v e r t i s e m e n t